Skip Navigation

Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin plus Docetaxel in Triple Negative Breast Cancer NeoPACT

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03639948

Study #:
STUDY00142487

Start Date:
Sep 03, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03639948

View Complete Trial Details & Eligibility at ClinicalTrials.gov